We have started a new contract service using digital PCR.
Digital PCR can be used to analyze samples that are difficult to analyze using conventional real-time PCR, such as rare mutations or quantitative methods that do not use calibration curves. Please contact us if you would like to try digital PCR on a small sample. Click here to contact us
We will exhibit our contract genome editing services at the 5th Pharmalabo EXPO Osaka (February 25-27, 2025 at Intex Osaka).
We will have a booth for our contract genome editing service at the 5th Pharmalabo EXPO Osaka to be held at Intex Osaka from February 25th to 27th.
Our company has been listed in the "Japanese Life Science Startup List" edited and managed by the Japan Bioindustry Association and NPO Kinki Bio-Industry Development Organization.
We are pleased to announce that our company has been listed in the "Japanese Life Science Startup List," jointly created and managed by the Japan Bioindustry Association and NPO Kinki Bio-Industry Development Organization. Click here for the list.
Our President, Dr Sugo, will be a lecturer at the webinar 'Fundamentals of genome editing technology and key points for its use in drug discovery research' organised by Research and Development Support Center CO.,LTD.
We are pleased to inform you that Dr Sugo, our company's president, will be a lecturer at the above web-only seminar (date and time: 12 June 2024 (Wed), 13:00-16:00), organised by Research and Development Support Center CO., LTD. Click here for more details of the lecture and registration for the seminar.
Our business was introduced in ThermoFisher Scientific's life science magazine "NEXT" No.67.
We are pleased to inform you that Thermo Fisher Scientific's life science magazine "NEXT" No.67, digitally published on October 25, 2023, features an introduction to our business titled "Diversified development of contract services and collaborative research with our unique genome editing and nucleic acid delivery technologies" Click here for the digital issue in Japanese.
Our President Dr. Sugo's review article is published in the October issue of Hokuryukan's "BIO Clinica" in Japanese.
His review "Propriety Nucleic Acid Delivery Technologies for Realizing a New Therapeutic Modality" is one of the topics for "Research and development of disease therapies using iPS cells" in the October issue published on September 25th, 2023. Click here for the summary of the review in English.
Notice about Decision of a Patent Grant
GenAhead Bio Inc. has been granted a patent for nucleic acid delivery technology in Japan. Click here for the press release